Metformin Aaa (Metformin Hydrochloride)

Metformin Hydrochloride is an oral antidiabetic that acts on glucose metabolism.

• Type 2 diabetes mellitus: improves glycemic control by reducing hepatic glucose output and enhancing insulin sensitivity.
• Prediabetes (impaired glucose tolerance): may delay progression to overt diabetes through modest glucose lowering.
• Polycystic ovary syndrome: can improve insulin resistance and assist in menstrual regularity.

• Metformin Hydrochloride primarily inhibits mitochondrial respiratory‑chain complex I, decreasing hepatic gluconeogenesis. This reduction in liver glucose production, together with increased peripheral glucose uptake and improved insulin receptor signaling, lowers circulating blood glucose. The drug does not stimulate insulin secretion, which contributes to its low risk of hypoglycaemia when used alone. Additionally, metformin modestly enhances fatty‑acid oxidation and may influence gut microbiota, further supporting metabolic control.

Metformin Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
• Diarrhea: frequent loose stools, especially during treatment initiation.
• Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects

• Lactic acidosis: a rare but life‑threatening accumulation of lactate.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: marked elevation of liver enzymes or liver failure.

When prescribing Metformin Hydrochloride, clinicians should observe several safety considerations.

• Renal function assessment: evaluate eGFR before initiation and periodically thereafter.
• Monitor blood glucose: adjust therapy based on glycaemic response and avoid hypoglycaemia.
• Avoid in severe hepatic impairment: risk of lactic acidosis increases.
• Use caution in elderly patients: reduced renal clearance may require dose adjustment.
• Contraindicated in known hypersensitivity: discontinue if allergic reaction occurs.
• Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride interacts with several medicines that can alter its efficacy or safety profile.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
• Cimetidine: can raise metformin plasma concentrations.
• Alcohol excess: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycaemic symptoms.
• NSAIDs: may impair renal perfusion, increasing metformin accumulation.